Boston Scientific diskutieren
Boston Scientific
WKN: 884113 / Symbol: BSX / Name: Boston Scient / Aktie / Ausrüstung & Versorgung / Large Cap /
77,00 €
-1,29 %
Boston Scientific Co. (NYSE: BSX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Truist Financial Co. from $59.00 to $66.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $62.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $64.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Raymond James from $61.00 to $67.00. They now have a "strong-buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $67.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Wells Fargo & Company from $70.00 to $72.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock, up previously from $65.00.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Needham & Company LLC from $60.00 to $71.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Raymond James from $67.00 to $73.00. They now have a "strong-buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at JPMorgan Chase & Co. from $60.00 to $72.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Royal Bank of Canada from $67.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Citigroup Inc. from $65.00 to $71.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Citigroup Inc. from $71.00 to $79.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Argus from $69.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Evercore ISI from $68.00 to $72.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Royal Bank of Canada from $70.00 to $78.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Robert W. Baird from $79.00 to $84.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Evercore ISI from $72.00 to $78.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Wells Fargo & Company from $72.00 to $82.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Neueste Beiträge
Tigress_Financial in Discuss Carnival Paired Ctf